Our research is focused on finding new clinical strategies to reduce chronic pain and for general pain management treatment. By carefully considering the pathology of the pain and treating the whole patient, we have been able to treat many patients with state-of-the-art therapies, including using advanced technology and modalities, that are successful in reducing or blocking pain and dramatically improving their quality of life.
Matthew Banks, PhD
Research in the Banks lab focuses on neural mechanisms of loss and recovery of consciousness under anesthesia, the overlap of these mechanisms with changes in arousal during natural sleep, the link between inflammation and brain function during postoperative delirium, and the mechanisms whereby psychedelics ameliorate psychiatric disorders.
My research interests focus on the incorporation of regional anesthesia techniques in the perioperative treatment of pain to improve patient outcomes as well as further evaluating patients’ understanding of pain and their postsurgical experience.
Our mission and our passion as a research group is to find a solution to prevent catastrophic outcomes by developing a clinically useful respiratory monitoring device.
Our research focuses on understanding the effects of vitamin C on biochemical and cellular damage in liver transplant recipients to optimize graft outcomes of this scarce resource.
Our current research focuses on quick implementation of therapy trial protocols to expeditiously bring novel treatments from the laboratory to the patient. We concentrate on phase 2 and phase 3 clinical trials. University of Wisconsin-Madison is ideal for these types of trials because of the efficient Office of Clinical Trials staffed with highly skilled and motivated coordinators.
Our research is focused on understanding changes in red cell mass and improving the storage and post-transfusion survival of blood.
The Hogan Laboratory focuses on responses to anesthesia and surgery arising from genomic and epigenomic variation.
Our research seeks to validate the immediate action of heparin and thereby the ability to safely go on cardiopulmonary bypass more rapidly than currently practiced even in patients with reduced ejection fraction.
Seeking novel treatments for chronic pain, we aim to understand the transition from acute to chronic pain by studying inhibitory neurons in the brain. An additional interest is the analgesic potential of subtype-selective GABA modulators.
Micah Long, MD
Dr. Micah Long hopes to improve the outcomes of organ transplant recipients by decreasing ischemia and reperfusion injury with vitamin C.
Research in the Pearce laboratory is focused on the mechanisms by which general anesthetics alter brain function. We are particularly interested in understanding how modulation of GABAA receptors impairs memory – a fundamental endpoint of anesthesia. For our studies we utilize expressed recombinant receptors and hippocampal brain slices to investigate the roles of specific subunit combinations and cell types in the control of learning and memory.
The Perouansky laboratory uses genetic tools available in the fruit fly (Drosophila melanogaster) to identify genetic determinants of anesthetic neurotoxicity.
Our research is focused on pediatric perioperative pain management strategies. By studying risks and complications in national and international databases, and through direct clinical research, our goal is to advance current anesthesia and prescription practice and improve care for the youngest patients.
Elizabeth Wilson, MD
Our research is focused on evaluating the best regional anesthetic techniques to improve post-operative pain and decrease use of opioid pain medications.